The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 23,601–23,700 of 31,469
Lin, J.-D. (2015) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2015.138 · Cited by 6
Mohammadi, S., Arefhosseini, S. R., Jafarabadi, M. A., Sharifnia, Z., & Ebrahimi‐Mameghani, M. (2016) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.36369 · Cited by 6
A study to evaluate surrogate markers of insulin resistance in forty euglycemic healthy subjects.
Gupta, A., & Jain, S. K. (2004) · PubMed · Cited by 6
Gottsäter, M., Balkau, B., Hatunic, M., Gabriel, R., Anderwald, C. H., Dekker, J., Lalic, N. M., & Nilsson, P. M. (2016) · Diabetic Medicine · doi:10.1111/dme.13172 · Cited by 6
Bath, P. M., Appleton, J. P., & Sprigg, N. (2016) · International Journal of Stroke · doi:10.1177/1747493016660099 · Cited by 6
García, F. J. (2015) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000527 · Cited by 6
Madrigal-Ruíz, P.-M., Navarro-Hernández, R. E., Ruíz-Quezada, S. L., Corona-Meraz, F.-I., Mercado, M. V.-D., Gómez-Bañuelos, E., Castro-Albarrán, J., Sandoval-García, F., Flores-Alvarado, L. J., & Martín-Márquez, B. T. (2016) · Journal of Diabetes Research · doi:10.1155/2016/5678946 · Cited by 8
Tarantino, G., Finelli, C., Gioa, S., Citro, V., Sala, N. L., & Gentile, M. (2016) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2016.1207249 · Cited by 6
Improved adipose tissue function with initiation of protease inhibitor-only ART
Maughan, R. T., Feeney, E. R., Capel, É., Capeau, J., Domingo, P., Giralt, M., Lange, J. M. A., Phanuphak, P., Cooper, D. A., Reiss, P., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw301 · Cited by 5
Yang, Y., Shin, J.-A., Yang, H. K., Lee, S., Ko, S., Ahn, Y., Yoon, K., & Cho, J. (2016) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2016.40.6.454 · Cited by 6
Insulin Resistance and Inflammation in Black Women with and without Breast Cancer: Cause for Concern
Griffith, K. A., Chung, S.-Y., Zhu, S., & Ryan, A. S. (2016) · Ethnicity & Disease · doi:10.18865/ed.26.4.513 · Cited by 6
Masuda, K., Noguchi, S., Ono, M., Ochi, T., Munekage, K., Okamoto, N., Suganuma, N., & Saibara, T. (2016) · Hepatology Research · doi:10.1111/hepr.12832 · Cited by 5
Fukatsu, M., Takai, Y., Matsunaga, S., Era, S., Ono, Y., Saito, M., Baba, K., & Seki, H. (2016) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.13223 · Cited by 9
de Luis, D. A., Izaola, O., Primo, D., et al. (2016) · Annals of Nutrition and Metabolism · doi:10.1159/000453676 · Cited by 6
Effect of Oxidative Stress in Hemodialysed Patients.
Peti, A., Csiky, B. S., Guth, E., et al. (2011) · PubMed · Cited by 6
Cabrera‐Rode, E., Rodríguez, J., Álvarez, A. Á., Valdés, R. E., Reyes, A. D., Cubas‐Dueñas, I., Tristá, S. E. T., & Díaz, Ó. D. (2017) · Journal of Dietary Supplements · doi:10.1080/19390211.2017.1304482 · Cited by 5
Jung, J., & Lee, M. (2017) · Journal of Nutrition and Health · doi:10.4163/jnh.2017.50.1.32 · Cited by 6
Lee, A. P., Mulligan, K., Schambelan, M., Murphy, E., & Weiss, E. (2017) · F1000Research · doi:10.12688/f1000research.11359.1 · Cited by 6
McClendon, E. E., Musani, S. K., Samdarshi, T. E., Khaire, S., Stokes, D. R., Hamburg, N. M., Sheffy, K., Mitchell, G. F., Taylor, H. A., Benjamin, E. J., et al. (2017) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2017.04.008 · Cited by 6
Ataş, H., & Gönül, M. (2017) · Advances in Dermatology and Allergology · doi:10.5114/pdia.2016.61630 · Cited by 6
Zeman, M., Vecka, M., Burda, M., TVRZICKÁ, E., Staňková, B., Macášek, J., & Žák, A. (2017) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2017.0040 · Cited by 6
Wang, J., Sheu, W. H., Lee, W., Lee, I., Lin, S., Lee, W.-L., Liang, K., & Lin, S. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.07.017 · Cited by 6
Fatness and Fitness With Cardiometabolic Risk Factors in Adolescents
Demmer, D. L., Beilin, L. J., Hands, B. P., Burrows, S., Cox, K. L., Oddy, W. H., & Mori, T. A. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00851 · Cited by 7
Serum concentrations of fetuin B in lipodystrophic patients
Miehle, K., Ebert, T., Kralisch, S., Hoffmann, A., Kratzsch, J., Schlögl, H., Stümvoll, M., & Faßhauer, M. (2017) · Cytokine · doi:10.1016/j.cyto.2017.10.028 · Cited by 6
Alemzadeh, R., & Kichler, J. (2017) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2017.0135 · Cited by 6
Ciresi, A., & Giordano, C. S. D. S. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0805-9 · Cited by 6
Caravaggio, F., Iwata, Y., Plitman, E., Chavez, S., Borlido, C., Chung, J. K., Kim, J., Agarwal, S. M., Gerretsen, P., Remington, G. J., et al. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.12.002 · Cited by 6
Leite, N., da Silva, L. R., de Jesus, Í. C., Lopes, W. A., Cavaglieri, C. R., Consentino, C. L. M., Radominski, R. B., de Souza, R. L. R., Tureck, L. V., & Alle, L. F. (2018) · Motriz Revista de Educação Física · doi:10.1590/s1980-6574201700si0017 · Cited by 6
Association of Low Urine pH with Insulin Resistance in Non-Diabetic Japanese Subjects
Shimodaira, M., Okaniwa, S., & Nakayama, T. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-122943 · Cited by 6
Festa, C., Mattei, L., Bitterman, O., Pintaudi, B., Framarino‐dei‐Malatesta, M., Bianchi, P., Trappolini, M., Colatrella, A., & Napoli, A. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0833-0 · Cited by 6
Serum uric acid in children and adolescents
Rosini, N., Pamplona-Cunha, H., Rosini, R. D., et al. (2018) · Jornal Brasileiro de Patologia e Medicina Laboratorial · doi:10.5935/1676-2444.20180003 · Cited by 6
Lin, W., Lin, P., Lee, C., et al. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12639 · Cited by 6
İnsülin Direnci ve Klinik Önemi
Savaş, H. B., & Gültekin, F. (2017) · SDÜ Tıp Fakültesi Dergisi · doi:10.17343/sdutfd.264358 · Cited by 8
Ige, A. O., Ajayi, O. A., & Adewoye, E. O. (2018) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2017-0104 · Cited by 6
Xu, X., Tian, X., Chen, Y., Yang, Z., Qu, Z., & Dong, J. (2018) · Peritoneal Dialysis International · doi:10.3747/pdi.2017.00177 · Cited by 6
Kutoh, E., Wada, A., Murayama, T., et al. (2018) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_578_17 · Cited by 6
Mizuno, S., Nakai, Y., Isayama, H., Yoshikawa, T., Saito, K., Takahara, N., Kogure, H., Tada, M., Hayashi, N., & Koike, K. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0083-4 · Cited by 6
Induction of uterine hyperplasia after cafeteria diet exposure
Gastiazoro, M. P., Schimpf, M. G., Durando, M., Lazzarino, G. P., Andreoli, M. F., Zierau, O., Luque, E. H., Ramos, J. G., & Varayoud, J. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.06.007 · Cited by 6
Circulating SCUBE1 levels in women with polycystic ovary syndrome
Erol, O., Elli̇dağ, H. Y., Özel, M. K., Uysal, A., Eren, E., & Yılmaz, N. (2018) · Journal of Turkish Society of Obstetric and Gynecology · doi:10.4274/tjod.25826 · Cited by 6
Ramírez, J. P., Leo, I. B., Huamán, H. A., et al. (2018) · Anales de la Facultad de Medicina · doi:10.15381/anales.v79i2.14937 · Cited by 6
Tiryaki, Ö., Usalan, C., Kul, S., Tarakçıoğlu, M., Sucu, M., Yıldız, F., & Çoban, S. (2018) · Clinical Transplantation · doi:10.1111/ctr.13375 · Cited by 5
Potential adverse effects of botanical supplementation in high-fat-fed female mice
Fuller, S. E., Yu, Y., Mendoza, T. M., Ribnicky, D., Cefalu, W. T., & Floyd, Z. E. (2018) · Biology of Sex Differences · doi:10.1186/s13293-018-0199-1 · Cited by 6
Kim, O. Y., Kwak, S., Lim, H., & Shin, M. (2018) · Nutrition Research · doi:10.1016/j.nutres.2018.09.008 · Cited by 6
Ali, A., el-kader, Z. A., El-Fattah, H. M. A., et al. (2018) · Journal of Scientific Research in Science /Journal of Scientific Research in Science · doi:10.21608/jsrs.2018.14120 · Cited by 6
Sidiropoulou, E. J., Paltoglou, G., Valsamakis, G., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-34075-6 · Cited by 6
Maslova, E., Hansen, S., Strøm, M., Halldorsson, T. I., Grunnet, L. G., Vaag, A. A., & Olsen, S. F. (2018) · Nutrients · doi:10.3390/nu10101534 · Cited by 7
Physical activity: the key to cardiometabolic risk reduction in obstructive sleep apnoea
Mendelson, M., & Flore, P. (2018) · European Respiratory Journal · doi:10.1183/13993003.01775-2018 · Cited by 6
Choi, Y. S., Klaric, J., & Beltran, T. (2018) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2018.0072 · Cited by 6
VE/VCO2 slope in lean and overweight women and its relationship to lean leg mass
Keller‐Ross, M. L., Chantigian, D. P., Evanoff, N. G., Bantle, A., Dengel, D. R., & Chow, L. S. (2018) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2018.10.009 · Cited by 6
Kim, K. E., Baek, K. S., Han, S., Kim, J. H., & Shin, Y. H. (2018) · Korean Journal of Pediatrics · doi:10.3345/kjp.2018.06639 · Cited by 6
Insulin resistance in children with familial hyperlipidemia
Terlemez, S., Bozdemir, E., Uçar, S. K., Kabaroğlu, C., Habif, S., Kayıkçıoğlu, M., & Çöker, M. (2018) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2018-0337 · Cited by 6
Oliveira, F. M. G. S. A., Tran, W. H., Lesser, D. J., Bhatia, R., Keens, T. G., Mittelman, S. D., Ward, S. L. D., & Khoo, M. C. K. (2018) · Pediatric Research · doi:10.1038/s41390-018-0226-2 · Cited by 6
Marra, N. F., Fernandes, M. T. B., de Melo, M. E., et al. (2018) · Acta Paediatrica · doi:10.1111/apa.14684 · Cited by 6
van Vuren, E. J., Malan, L., von Känel, R., Magnusson, M., Lammertyn, L., & Malan, N. T. (2018) · Diabetes and Vascular Disease Research · doi:10.1177/1479164118816221 · Cited by 6
Metabolic Health in Severely Obese Subjects: A Descriptive Study
Worm, D., Madsbad, S., & Hansen, D. L. (2019) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2018.0083 · Cited by 6
Marmonti, E., Busquets, S., Toledo, M., Ricci, M., Bria, J., Oliva, F., López-Pedrosa, J. M., Manzano, M., Rueda, R., López-Soriano, F. J., et al. (2018) · JCSM Rapid Communications · doi:10.1002/j.2617-1619.2018.tb00007.x · Cited by 6
Effects of vitamin D supplementation on cardiovascular risk factors in shift workers
Fajardo, V. C., de Oliveira, F. L. P., Machado-Coelho, G. L. L., Pimenta, F. A. P., de Freitas, S. N., Ribeiro, A. L. P., Soares, M. M. S., Lauria, M. W., Farias, R. D. C., França, I. B., et al. (2019) · Medicine · doi:10.1097/md.0000000000015417 · Cited by 6
Blond, M. B., Schnurr, T. M., Rosenkilde, M., Quist, J. S., Gram, A. S., Reichkendler, M. H., Auerbach, P., Nordby, P., Skovgaard, L. T., Ribel‐Madsen, R., et al. (2019) · Physiological Genomics · doi:10.1152/physiolgenomics.00101.2018 · Cited by 6
Bettini, S., Bordigato, E., Milan, G., Prà, C. D., Favaretto, F., Belligoli, A., Sanna, M., Serra, R., D, M. F. M., Prevedello, L., et al. (2019) · Obesity Facts · doi:10.1159/000499717 · Cited by 6
El-Kharashi, O. A., Mohamed, D. I., Khairy, E., Ezzat, S. F., & Zaki, W. S. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.05.024 · Cited by 7
Panda, V. S., Shah, T., & Sudhamani, S. (2019) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2019-0139 · Cited by 6
Cho, Y., Lee, Y., Kang, E. S., Soo, B., & Lee, B. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.04.014 · Cited by 6
Salivary cortisol is not associated with incident insulin resistance or type 2 diabetes mellitus
Gariani, K., Marques-Vidal, P. M., Waeber, G., Vollenweider, P., & Jornayvaz, F. R. (2019) · Endocrine Connections · doi:10.1530/ec-19-0251 · Cited by 6
Janšáková, K., Lengyelová, E., Pribulová, N., Somoza, V., Celec, P., Šebeková, K., Ostatníková, D., & Tóthová, Ľ. (2019) · Physiological Research · doi:10.33549/physiolres.934102 · Cited by 6
Meron, M. K., Xu, S., Glesby, M. J., Qi, Q., Hanna, D. B., Anastos, K., Kaplan, R. C., & Kizer, J. R. (2019) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2019.0099 · Cited by 6
Dewi, M., Carlson, S. E., Gustafson, K. M., Sullivan, D. K., Wick, J., & Hull, H. R. (2017) · PubMed · doi:10.6133/apjcn.062017.s11 · Cited by 6
Zecharia, D., Rauch, M., Sharabi‐Nov, A., et al. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00099.2019 · Cited by 6
Ji, L., Sun, N., Zhang, Y., Zhang, L., Shen, S., Wang, X., Li, Q., Dong, L., Ren, W., Qi, L., et al. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13884 · Cited by 6
Su, H., Ma, X., Shen, Y., et al. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01452-0 · Cited by 6
Assessment of epicardial adipose tissue in young obese children
van Hoek, E., Koopman, L. P., Feskens, E. J. M., & Janse, A. J. (2019) · Child and Adolescent Obesity · doi:10.1080/2574254x.2019.1688594 · Cited by 6
Raees, A., Bakhamis, A., Mohamed‐Ali, V., Bashah, M., Al-Jaber, M., Abraham, D., Clapp, L. H., & Orie, N. N. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117039 · Cited by 6
Assessment of hepatic steatosis algorithms in non-alcoholic fatty liver disease.
Eremić-Kojić, N., Đerić, M., Govorčin, M., Balać, D., Kresoja, M., & Kojić-Damjanov, S. (2018) · Europe PMC (PubMed Central) · Cited by 6
Loureiro, L. M., Cordeiro, A., Mendes, R., Luna, M., Pereira, S., Saboya, C. J., & Ramalho, A. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s210616 · Cited by 6
Sudha, V., Lakshmipriya, N., Gayathri, R., Shanmugam, S., Srinivasan, R., Krishnaswamy, K., Jeevan, R. G., Ranjit Unnikrishnan, I., Anjana, R. M., & Mohan, V. (2019) · Journal of Diabetology · doi:10.4103/jod.jod_23_19 · Cited by 6
Primo, D., Izaola, O., & de Luis, D. A. (2019) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2019.09.010 · Cited by 6
Zakaria, S., Hasan, R. A., Mahmoud, M. F., Fayoumi, H. M. E., & Mahmoud, A. A. A. (2020) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13257 · Cited by 6
Mir, E., Moazzami, M., Bijeh, N., Dokht, E. H., & Rahimi, N. (2020) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-019-00790-7 · Cited by 7
Gomes, S. V., Dias, B. V., Pereira, R. R., Lúcio, K. D. P., de Souza, D. M. S., Talvani, A., Brandão, G. C., Cosenza, G. P., de Queiroz, K. B., & Costa, D. C. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.103780 · Cited by 7
Hyun, M. H., Jang, J. W., Choi, B. G., Na, J. O., Choi, C. U., Kim, J. W., Kim, E. J., Rha, S., Park, C. G., Lee, E. M., et al. (2020) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13272 · Cited by 6
Effect of One‐Year Growth Hormone Therapy on Cardiometabolic Risk Factors in Boys with Obesity
Wu, J., Zhao, F., Zhang, Y., et al. (2020) · BioMed Research International · doi:10.1155/2020/2308124 · Cited by 6
Papadakis, E. P., Sarigianni, M., Τζιόμαλος, Κ., Mavromatidis, G., & Panidis, D. (2020) · HORMONES · doi:10.1007/s42000-020-00182-1 · Cited by 6
Predicting Skeletal Muscle and Whole-Body Insulin Sensitivity Using NMR-Metabolomic Profiling
Klén, R., Honka, M., Hannukainen, J. C., Huovinen, V., Bucci, M., Latva‐Rasku, A., Venäläinen, M. S., Kalliokoski, K. K., Virtanen, K. A., Läutamaki, R., et al. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa026 · Cited by 6
Kısa, B., Sert, Ü. Y., Kansu-Celik, H., et al. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2020.1739714 · Cited by 6
Derosa, G., Cicero, A. F. G., Carbone, A., Querci, F., Fogari, E., D’Angelo, A., & Maffioli, P. (2013) · Inflammation · doi:10.1007/s10753-013-9724-x · Cited by 6
RetractedLi, Z., Lu, C., Qiu, J., Liu, S., Liu, X., Ma, S., & Lai, R. (2018) · PubMed Central · Cited by 6
Lipoprotein insulin resistance score in nondiabetic patients with obesity after bariatric surgery
Zhang, R., Lin, B., Parikh, M., Fisher, E. A. A., Berger, J. S., Alemán, J. O., & Heffron, S. P. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2020.05.008 · Cited by 6
Lin, H., Zhu, L., Baker, S. S., et al. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.06.126 · Cited by 6
Lu, W.-A., Chen, Y., Wang, C.-H., & Kuo, C. (2020) · Life · doi:10.3390/life10080145 · Cited by 6
Shah, A. M., PRASAD, M. A., Devjani, S., Rai, P., Ashby‐Thompson, M., Yu, W. W., Gallagher, D., & Laferrère, B. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04905-6 · Cited by 6
Sentinelli, F., Bertoccini, L., Incani, M., Pani, M. G., David, F., Bailetti, D., Boi, A., Barchetta, I., Cimini, F. A., Mannino, A. C., et al. (2020) · Endocrine Research · doi:10.1080/07435800.2020.1804929 · Cited by 6
Okan, G., Baki, A. M., Yorulmaz, E., Doğru‐Abbasoğlu, S., & Vural, P. (2020) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23564 · Cited by 6
Zhang, R., Cai, X., Du, Y., Liu, L., Han, X., Liu, W., Gong, S., Zhou, X., Wang, X., Wen, X., et al. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107750 · Cited by 6
Yagi, T., Ataka, K., Cheng, K., Suzuki, H., Ogata, K., Yoshizaki, Y., Takamine, K. T., Kato, I., Miyawaki, S., Inui, A., et al. (2020) · Food & Nutrition Research · doi:10.29219/fnr.v64.4226 · Cited by 7
Mele, C., Crinò, A., Fintini, D., Mai, S., Convertino, A., Bocchini, S., Paolo, P. D., Grugni, G., Aimaretti, G., Scacchi, M., et al. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01444-w · Cited by 7
Mohammed, E. D., Zhang, Z., Tian, W., Gangarapu, V., Al-Gendy, A. A., Chen, J., Wei, J., & Sun, B. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153388 · Cited by 6
Vaňková, M., Vacínová, G., Včelák, J., Vejražková, D., Lukášová, P., Rusina, R., Holmerová, I., Jarolímová, E., Vaňková, H., & Bendlová, B. (2020) · Physiological Research · doi:10.33549/physiolres.934536 · Cited by 6
Guha, N., Nevitt, S. P., Francis, M., Böhning, W., Böhning, D., Sönksen, P. H., & Holt, R. I. G. (2020) · Clinical Endocrinology · doi:10.1111/cen.14370 · Cited by 6
Rodrigues, L. I. I., Tess, B. H., Griep, R. H., Fonseca, M. J. M., Pereira, A. C., Diniz, M. D. F. H. S., Lotufo, P. A., Benseñor, I. M., & Santos, I. S. (2020) · International Archives of Occupational and Environmental Health · doi:10.1007/s00420-020-01613-7 · Cited by 7
Zou, J., Liu, Y., Xu, H., Meng, L., Zou, J., Qian, Y., Chen, B., Yi, H., Guan, J., & Yin, S. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-3165 · Cited by 6
Dorling, J. L., Thackray, A. E., King, J. A., Pucci, A. B. F., Goltz, F. R., Batterham, R. L., & Stensel, D. J. (2020) · Nutrients · doi:10.3390/nu12123857 · Cited by 6
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
